Magnetar Financial LLC Arvinas, Inc. Transaction History

Magnetar Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $544,112 - $898,698	22,245 Added 112.65%	41,992 $1.12 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $718,395 - $1.03 Million	19,747 New	19,747 $815,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $151,036 - $204,414	-2,506 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $139,404 - $203,676	-2,117 Reduced 45.79%	2,506 $206,000
Q3 2021 Nov 12, 2021	BUY	$73.2 - $107.87 $338,403 - $498,683	4,623 New	4,623 $380,000

224

70.9M

1.52M

346K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $945M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.